Genetic Risk Testing—Policyholder Misconceptions and Benefits to Insurers 

Sir Peter Donnelly // August 13, 2024

(Image credit: Sora Shimazaki/Pexels.)

The last five years have seen a massive change in our ability to understand and measure the genetic component of risk for common diseases—like cardiovascular disease, diabetes and common cancers. These are the diseases responsible for most of the mortality and morbidity in our populations. People can now provide DNA through an at-home saliva sample and learn more about their health risks than ever before, equipping themselves with a personalized understanding of their future, and giving them tools to live longer, healthier lives. An even more recent

Read More>>